Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...
adaptive behavior and tremor” and went ahead with filing a new drug application with the FDA. Applied had planned to ask for U.S. approval on the strength of biomarker data, only for the FDA to ...
The Fiji Police Force is prioritizing efforts to enhance its responsiveness, particularly in law enforcement and drug control ...
Stock of Applied Therapeutics, Inc. surges as FDA skips AdCom for AT-007 in galactosemia. Read more on recent developments ...
1d
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
CYB004 Phase 2 Program Outline Dr. Atul R. Mahableshwarkar M.D., DLFAPA ... Dr. Macek brings decades of pharmaceutical industry experience in new drug development across all phases of research ...
Researchers introduce magnetic soft robots for precision drug delivery, offering programmable control of multiple medications ...
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback